Jfs Wealth Advisors, LLC Horizon Therapeutics Public LTD CO Transaction History

Jfs Wealth Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 19, 2023	SELL	$107.32 - $113.5 $107 - $113	-1 Reduced 1.56%	63 $6,000
Q4 2022 Feb 13, 2023	BUY	$62.39 - $113.8 $3,369 - $6,145	54 Added 540.0%	64 $7,000
Q3 2022 Oct 21, 2022	SELL	$58.92 - $84.67 $4,654 - $6,688	-79 Reduced 88.76%	10 $1,000
Q2 2022 Aug 02, 2022	SELL	$79.4 - $116.36 $2,937 - $4,305	-37 Reduced 29.37%	89 $7,000
Q1 2022 May 02, 2022	SELL	$86.42 - $109.81 $5,617 - $7,137	-65 Reduced 34.03%	126 $13,000

Q4 2021 Feb 03, 2022	SELL	$98.56 - $119.91 $35,481 - $43,167	-360 Reduced 65.34%	191 $21,000
Q3 2021 Nov 09, 2021	BUY	$91.91 - $110.37 $50,642 - $60,813	551 New	551 $60,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Jfs Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Jfs Wealth Advisors, LLC with notifications on news.